J L Jorcano
Overview
Explore the profile of J L Jorcano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1824
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Risueno I, Valencia L, Jorcano J, Velasco D
APL Bioeng
. 2021 Oct;
5(4):049901.
PMID: 34703971
[This corrects the article DOI: 10.1063/5.0046376.].
2.
Risueno I, Valencia L, Jorcano J, Velasco D
APL Bioeng
. 2021 Jul;
5(3):030901.
PMID: 34258497
Over the last few years, several advances have been made toward the development and production of human skin models for the analysis and testing of cosmetic and pharmaceutical products. However,...
3.
Valencia L, Canalejas-Tejero V, Clemente M, Fernaud I, Holgado M, Jorcano J, et al.
Sci Rep
. 2021 Jun;
11(1):13160.
PMID: 34162909
Microfluidic-based tissues-on-chips (TOCs) have thus far been restricted to modelling simple epithelia as a single cell layer, but likely due to technical difficulties, no TOCs have been reported to include...
4.
Alonso A, Weber T, Jorcano J
Rouxs Arch Dev Biol
. 2017 Mar;
196(1):16-21.
PMID: 28305656
We have identified a cDNA coding for the murine keratin D from a collection of clones representing F9 teratocarcinoma stem cell mRNA sequences. These sequences are synthesized specifically after the...
5.
Alameda J, Moreno-Maldonado R, Navarro M, Bravo A, Ramirez A, Page A, et al.
Oncogene
. 2010 Sep;
29(50):6522-32.
PMID: 20838385
In this study, we demonstrate that the expression in tumorigenic epidermal cells of a catalytically inactive form of CYLD (CYLD(C/S)) that mimics the identified mutations of cyld in human tumors...
6.
Escamez M, Garcia M, Cuadrado-Corrales N, Llames S, Charlesworth A, De Luca N, et al.
Br J Dermatol
. 2010 Feb;
163(1):155-61.
PMID: 20184583
Background: Dystrophic epidermolysis bullosa (DEB) is a genodermatosis caused by mutations in COL7A1. The clinical manifestations are highly variable from nail dystrophy to life-threatening blistering, making early molecular diagnosis and...
7.
Carretero M, Escamez M, Prada F, Mirones I, Garcia M, Holguin A, et al.
Histol Histopathol
. 2006 Jul;
21(11):1233-47.
PMID: 16874666
The rapid advances associated with the Human Genome Project combined with the development of proteomics technology set the bases to face the challenge of human gene therapy. Different strategies must...
8.
Essayem S, Kovacic-Milivojevic B, Baumbusch C, McDonagh S, Dolganov G, Howerton K, et al.
Oncogene
. 2005 Oct;
25(7):1081-9.
PMID: 16247468
Focal adhesion kinase (FAK) is a critical component in transducing signals downstream of both integrins and growth factor receptors. To determine how the loss of FAK affects the epidermis in...
9.
Sterneck E, Zhu S, Ramirez A, Jorcano J, Smart R
Oncogene
. 2005 Oct;
25(8):1272-1276.
PMID: 16205634
The CCAAT/enhancer binding protein beta (C/EBP beta) is implicated in the regulation of many different molecular and physiological processes. Mice with a germline deletion of C/EBP beta (C/EBP beta(-/-)) display...
10.
Del Rio M, Gache Y, Jorcano J, Meneguzzi G, Larcher F
Gene Ther
. 2004 Sep;
11 Suppl 1:S57-63.
PMID: 15454958
Inherited and acquired disorders are liable to treatment with somatic gene therapy. The skin, and in particular epidermal cells, are particularly suited to genetic manipulation and follow-up of therapeutic effects....